ARATANA THERAPEUTICS, INC. — Form D

ARATANA THERAPEUTICS, INC. of KANSAS CITY, KS, a company, filed a Form D exempt-offering notice with the SEC on 2012-12-28. The offering totals $12.0M. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Rip GerberDirectorKansas City, KS
Jay LichterDirectorLa Jolla, CA
Ronald L. MeeusenDirectorKansas City, KS
Linda RhodesDirectorSan Francisco, CA
Steven St. PeterDirectorKansas City, KS
Craig ToomanDirectorLondon, X0
John Vander VortDirectorKansas City, KS
Linda RhodesExecutive OfficerSan Francisco, CA
Steven St. PeterExecutive OfficerKansas City, KS
David RosenExecutive OfficerNew York, NY
Jay LichterExecutive OfficerLa Jolla, CA
Jay Lichter, Ph.D.DirectorLa Jolla, CA
Jay Lichter, Ph.D.Executive OfficerLa Jolla, CA
Ron MeeusenDirectorEmeryville, CA
Robert GerberDirectorCARLSBAD, CA
Ernst A Heinen, D.V.M., Ph.D.Executive OfficerKansas City, KS
Steven L St. Peter, M.D.DirectorKansas City, KS
Steven L St. Peter, M.D.Executive OfficerKansas City, KS
Linda L Rhodes, V.M.D., Ph.D.DirectorKansas City, KS
Linda L Rhodes, V.M.D., Ph.D.Executive OfficerKansas City, KS
Ronald L Meeusen, Ph.D.DirectorBurr Ridge, IL
Louise A MawhinneyExecutive OfficerKansas City, KS
Craig L ToomanDirectorFar Hills, NJ
John L Vander VortDirectorBoston, MA
Julia A StephanusExecutive OfficerKansas City, KS

Other filings by this issuer (3)

FiledFormOfferingSold
2013-10-23D$29.8M$29.8M
2011-10-25D$15.5M
2011-01-07D$20.0M$10.0M

More